| 2.79 0.03 (1.09%) | 11-29 12:47 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 5 | 1-year : | 6.23 |
| Resists | First : | 4.28 | Second : | 5.34 |
| Pivot price | 3.21 |
|||
| Supports | First : | 2.56 | Second : | 2.13 |
| MAs | MA(5) : | 2.76 |
MA(20) : | 3.39 |
| MA(100) : | 3.08 |
MA(250) : | 2.81 |
|
| MACD | MACD : | -0.3 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 10.9 |
D(3) : | 10.4 |
| RSI | RSI(14): 37.9 |
|||
| 52-week | High : | 5.34 | Low : | 1.85 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ RKDA ] has closed above bottom band by 33.6%. Bollinger Bands are 172.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 29 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 2.85 - 2.87 | 2.87 - 2.88 |
| Low: | 2.73 - 2.74 | 2.74 - 2.76 |
| Close: | 2.74 - 2.76 | 2.76 - 2.78 |
Arcadia Biosciences, Inc. produces and markets plant-based health and wellness products in the United States. It engages in developing crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. The company was incorporated in 2002 and is headquartered in Davis, California.
Wed, 20 Nov 2024
Arcadia Biosciences' Q3 Earnings Miss Estimates, Sales Increase Y/Y - MSN
Mon, 18 Nov 2024
Arcadia Biosciences' Q3 Earnings Miss Estimates, Sales Increase Y/Y - Yahoo Finance
Wed, 13 Nov 2024
Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q3 2024 Earnings Call Transcript - Insider Monkey
Wed, 13 Nov 2024
Arcadia Biosciences Inc (RKDA) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic Challenges - GuruFocus.com
Tue, 12 Nov 2024
Arcadia Biosciences Reports Strong Q3 2024 Growth - TipRanks
Tue, 12 Nov 2024
Arcadia Biosciences: Q3 Earnings Snapshot - Houston Chronicle
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Basic Materials
|
|
|
Industry:
Agricultural Inputs
|
|
| Shares Out | 1 (M) |
| Shares Float | 1 (M) |
| Held by Insiders | 2.7 (%) |
| Held by Institutions | 4.5 (%) |
| Shares Short | 25 (K) |
| Shares Short P.Month | 22 (K) |
| EPS | -6.77 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 7.53 |
| Profit Margin | -112.5 % |
| Operating Margin | -114.6 % |
| Return on Assets (ttm) | -38.8 % |
| Return on Equity (ttm) | -52.7 % |
| Qtrly Rev. Growth | -3.8 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 3.8 |
| EBITDA (p.s.) | -8.71 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -12 (M) |
| Levered Free Cash Flow | -7 (M) |
| PE Ratio | -0.42 |
| PEG Ratio | 0 |
| Price to Book value | 0.37 |
| Price to Sales | 0.73 |
| Price to Cash Flow | -0.33 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|